Merendino Lauren

Officer at DAWN; Chief Commercial Officer at Myovant Sciences Ltd.

Sold, on record
$343k
Dollars the filings state
Form 4 sales
8
Latest Feb 17, 2026
Form 144 notices
3
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Myovant Sciences Ltd.Plan not stated
    Jan 18, 2023 2023

    Sold 2,008 shares at $26.89 ($54k)

    Merendino Lauren, Chief Commercial Officer

    Sold 1.2% of holdings ($4.6M position)169,538 shares left1.2x usual sizeFiling

  2. 2 Form 144 notice DAWNNotice
    May 16, 2025 +849 days

    Filed to sell 3,927 shares ($25k)

    Merendino Lauren, Officer

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale DAWNNo plan
    May 16, 2025 same day

    Sold 3,927 shares at $6.26 ($25k)

    Merendino Lauren, Chief Commercial Officer

    No 10b5-1 planSold 10% of holdings ($245k position)35,161 shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 4 sale DAWNNo plan
    Aug 18, 2025 +94 days

    Sold 3,766 shares at $6.77 ($25k)

    Merendino Lauren, Chief Commercial Officer

    No 10b5-1 planSold 8.2% of holdings ($309k position)41,931 shares leftFiling

  5. 5 Form 144 notice DAWNNotice
    Nov 17, 2025 +91 days

    Filed to sell 3,726 shares ($33k)

    Merendino Lauren, Officer

    No 10b5-1 planFiling

  6. 6 Form 4 sale DAWNNo plan
    Nov 17, 2025 same day

    Sold 3,726 shares at $8.91 ($33k)

    Merendino Lauren, Chief Commercial Officer

    No 10b5-1 planSold 6.8% of holdings ($486k position)50,809 shares leftFollows a Form 144Filing

  7. 7 Form 144 notice DAWNNotice
    Feb 17, 2026 +92 days

    Filed to sell 5,814 shares ($67k)

    Merendino Lauren, Officer

    No 10b5-1 plan1.5x usual sizeFiling

  8. 8 Form 4 sale DAWNNo plan
    Feb 17, 2026 same day

    Sold 5,814 shares at $11.60 ($67k)

    Merendino Lauren, Chief Commercial Officer

    No 10b5-1 planSold 8.8% of holdings ($765k position)60,157 shares left1.5x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Merendino Lauren
Source
Feb 17, 2026Feb 18, 2026DAWNChief Commercial OfficerForm 4 sale5,814$67k8.8%No planSEC
Feb 17, 2026Feb 17, 2026DAWNOfficerForm 144 notice5,814$67kNoticeSEC
Nov 17, 2025Nov 18, 2025DAWNChief Commercial OfficerForm 4 sale3,726$33k6.8%No planSEC
Nov 17, 2025Nov 17, 2025DAWNOfficerForm 144 notice3,726$33kNoticeSEC
Aug 18, 2025Aug 19, 2025DAWNChief Commercial OfficerForm 4 sale3,766$25k8.2%No planSEC
May 16, 2025May 19, 2025DAWNChief Commercial OfficerForm 4 sale3,927$25k10.0%No planSEC
May 16, 2025May 16, 2025DAWNOfficerForm 144 notice3,927$25kNoticeSEC
Jan 18, 2023Jan 20, 2023Myovant Sciences Ltd.Chief Commercial OfficerForm 4 sale2,008$54k1.2%Plan not statedSEC
Oct 18, 2022Oct 20, 2022Myovant Sciences Ltd.Chief Commercial OfficerForm 4 sale1,703$43k1.0%Plan not statedSEC
Jul 18, 2022Jul 20, 2022Myovant Sciences Ltd.Chief Commercial OfficerForm 4 sale1,704$22k1.0%Plan not statedSEC
Apr 19, 2022Apr 21, 2022Myovant Sciences Ltd.Chief Commercial OfficerForm 4 sale7,049$74k3.9%Plan not statedSEC